Melanotan II lipolysis research extends the MT-2 research cluster into adipose tissue biology, where the melanocortin 5 receptor mediates a distinctive lipolytic response that is one of the less studied but mechanistically important aspects of MT-2 pharmacology. This article reviews the MC5R biology and the published research on MT-2 effects on adipocyte lipolysis in rodent research models.
Melanotan II Lipolysis Research: MC5R Adipose Tissue Studies
Melanotan II · Published April 14, 2026 · Updated May 18, 2026 · 7 min read
Quick Answer
Melanotan II lipolysis research examines MC5R-mediated adipose tissue effects and metabolic profile changes in rodent models. Studies measure lipolytic markers, adipocyte biology, free fatty acid release, and integrated metabolic biomarkers underlying broad-spectrum melanocortin receptor activation. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- MC5R Expression in Adipose Tissue
- Published MC5R Research with MT-2
- Depot Specificity in Adipose Research
- Integration with Central Melanocortin Effects
- Comparison with Other Lipolytic Tools
- Relationship to Other Cluster Content
- Research Peptide Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is Melanotan II in research contexts?
+
Melanotan II is a synthetic cyclic heptapeptide non-selective melanocortin receptor agonist that binds MC1R, MC3R, MC4R, and MC5R. It is studied in preclinical research for pigmentation, central appetite signaling, and melanocortin pharmacology.
How does MC5R signaling affect lipolysis in research?
+
MC5R is expressed in adipose tissue and modulates lipolysis through cAMP signaling. Melanotan II's MC5R agonism stimulates fatty acid release from adipocytes in research models, contributing to body composition effects beyond MC4R-mediated food intake reduction.
What adipose endpoints are measured with Melanotan II?
+
Endpoints include free fatty acid release in vitro from isolated adipocytes, glycerol release as a lipolysis marker, triglyceride content of fat depots, adipocyte size, and integrated body composition measures via DEXA or qMR in rodent models.
Is Melanotan II approved for human use?
+
No. Melanotan II is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- MC1R
- Melanocortin 1 receptor, the GPCR on melanocytes mediating pigmentation effects of melanocortin agonists.
- MC4R
- Melanocortin 4 receptor, primarily expressed in the hypothalamus and central nervous system, regulating appetite and sexual behavior.
- MC5R
- Melanocortin 5 receptor, broadly distributed and implicated in exocrine function and lipolysis.
- Cyclic Peptide
- A peptide whose backbone or side chains are joined into a ring, conferring increased stability and receptor selectivity.
- Bremelanotide
- A cyclic melanocortin agonist analog of Melanotan II with reduced MC1R activity, studied for central effects.
- Lipolysis
- The breakdown of triglycerides in adipocytes to release free fatty acids, a GH-stimulated process.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
